EPIBATIDINE: FROM FROG ALKALOID TO ANALGESIC CLINICAL CANDIDATES. A TESTIMONIAL TO "TRUE GRIT"!

被引：19

作者：

Garraffo, H. Martin ^{[1
]}

Spande, Thomas F. ^{[1
]}

Williams, Michael ^{[2
]}

机构：

[1] NIDDK, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA

[2] Cephalon Inc, Discovery Res, W Chester, PA USA

来源：

HETEROCYCLES | 2009年 / 79卷

关键词：

Poison Frog; Alkaloid; Epibatidine; Nicotinic Agonist; Straub-Tail; NICOTINIC ACETYLCHOLINE-RECEPTORS; IN-VITRO; POTENT; CHEMISTRY; DISCOVERY; AGONIST; ABT-594; ABT-418; LIGAND; SKIN;

D O I：

10.3987/REV-08-SR(D)5

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

A routine toxicity test of the alkaloid extract from the Ecuadoran poison frog Epipedobates anthonyi gave a Straub-tail (S-T) response on sub-cutaneous (sc) injection in mice, a phenomenon never seen before from any poison frog alkaloid. It is characteristic of opioids; however, in this instance it was not blocked by a morphine-antagonist, naloxone. Its site of action was soon shown to be a nicotinic receptor. The determination of the structure of this novel analgesic named epibatidine has led to a renaissance of research into controlling pain via nicotinic pathways (thereby minimizing the risk of tolerance/addiction) and the synthesis of many analogs, some of which are discussed.

引用

页码：207 / 217

页数：11

共 35 条

[31]

SULLIVAN JP, 1994, J PHARMACOL EXP THER, V271, P624

[32] A-85380 [3-(2(S)-azetidinylmethoxy)pyridine]: In vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand [J].

Sullivan, JP ;

DonnellyRoberts, D ;

Briggs, CA ;

Anderson, DJ ;

Gopalakrishnan, M ;

PiattoniKaplan, M ;

Campbell, JE ;

McKenna, DG ;

Molinari, E ;

Hettinger, AM ;

Garvey, DS ;

Wasicak, JT ;

Holladay, MW ;

Williams, M ;

Arneric, SP .

NEUROPHARMACOLOGY, 1996, 35 (06) :725-734

[33] A common pumiliotoxin from poison frogs exhibits enantioselective toxicity against mosquitoes [J].

Weldon, Paul J. ;

Kramer, Matthew ;

Gordon, Scott ;

Spande, Thomas F. ;

Daly, John W. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (47) :17818-17821

[34] Synthesis of UB-165: A novel nicotinic ligand and anatoxin-a/epibatidine hybrid [J].

Wright, E ;

Gallagher, T ;

Sharples, CGV ;

Wonnacott, S .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (22) :2867-2870

[35] The NIH roadmap [J].

Zerhouni, E .

SCIENCE, 2003, 302 (5642) :63-+

← 1 2 3 4 →